Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Hepatology
•
Hepatology
What is your approach to a patient with "low" liver enzymes?
Is there any clinical significance on patient outcomes to these findings?
Related Questions
In patients with MASLD, would you consider management with off-label metformin, pioglitazone (despite weight gain risk), GLP-1 RA, or simply intensify lifestyle and monitor?
How do you counsel patients on the risks vs benefits of naltrexone for alcohol use disorder with persistently elevated liver enzymes?
How do you decide between anticoagulation or portal vein recanalization in a patient with portal vein thrombosis?
In patients with MASLD and F2–F3 fibrosis, would you initiate Resmetirom even if they are not making active lifestyle changes?
Do you always consider ADPCKD or ARPCKD in a patient who is incidentally found to have liver and renal cysts?
When would you consider use of EUS guided liver biopsy over percutaneous and/or transjugular?
Do you avoid peritoneal dialysis in cirrhotic patients with ascites?
What is your strategy to manage peri-procedural bleeding risk in patients with cirrhosis?
What is your clinical approach to the evaluation of cytopenias in patients with end-stage liver disease?
How would you approach the management of asymptomatic ALT and GGT elevation in an older adult patient with depression with psychosis and without history of hepatitis who recently had dose of quetiapine increased and new initiation of SNRI?